OncoSec Medical (FRA:ONMA) Other Long Term Assets : €0.52 Mil (As of Jan. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Other Long Term Assets?

OncoSec Medical's other long-term assets for the quarter that ended in Jan. 2023 was €0.52 Mil.

OncoSec Medical's quarterly other long-term assets declined from Jul. 2022 (€0.61 Mil) to Oct. 2022 (€0.59 Mil) but then stayed the same from Oct. 2022 (€0.59 Mil) to Jan. 2023 (€0.52 Mil).

OncoSec Medical's annual other long-term assets declined from Jul. 2020 (€0.28 Mil) to Jul. 2021 (€0.23 Mil) but then increased from Jul. 2021 (€0.23 Mil) to Jul. 2022 (€0.61 Mil).

OncoSec Medical Other Long Term Assets Historical Data

The historical data trend for OncoSec Medical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Other Long Term Assets Chart

OncoSec Medical Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Other Long Term Assets

Get a 7-Day Free Trial

0.31

0.32

0.28

0.23

0.61

OncoSec Medical Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Other Long Term Assets	Get a 7-Day Free Trial															0.47	0.49	0.61	0.59	0.52

OncoSec Medical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

OncoSec Medical (FRA:ONMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ONCSQ:USA

Address

24 North Main Street, Pennington, NJ, USA, 08534

Website

https://www.oncosec.com

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical (FRA:ONMA) Headlines

No Headlines